cola lipid c efficacy against albicans Candida accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2α signaling Candida albicans gains azole resistance
Candida albicans gains azole resistance by altering sphingolipid composition Nature Communications Antifungal efficacy of pyrolysis derived bio oil aqueous phases from Tropical plant biomass against Candida auris Scientific Reports CO2 enhances the formation, nutrient scavenging and drug resistance properties of C. albicans biofilms npj Biofilms and Microbiomes Frontiers Pore forming peptide C14R exhibits potent antifungal activity against clinical isolates of Candida albicans and Candida auris Antifungal Efficacy of Antimicrobial Peptide Octominin II against Candida albicans
Pay in 4 interest-free payments of $7.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




